Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-02

Clinical Trial Update: HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial [Phase 2, Phase 3]

View source ↗

Summary

This item reports a multicenter randomized trial investigating high-definition transcranial direct current stimulation (HD-tDCS) for amyotrophic lateral scleros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HD-tDCS (High-definition transcranial direct current stimulation)

Snippet

Sponsor: Universidade Federal do Rio Grande do Norte | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING